Show simple item record

dc.contributor.authorJames, E
dc.contributor.authorHook, J
dc.contributor.authorStenning, S
dc.contributor.authorCook, A
dc.contributor.authorCoyle, C
dc.contributor.authorPetrie, J
dc.contributor.authorKaplan, R
dc.contributor.authorMcNeish, I
dc.contributor.authorPerren, T
dc.contributor.authorNaik, R
dc.contributor.authorBanerjee, S
dc.contributor.authorLedermann, J
dc.contributor.authorClamp, Andrew R
dc.date.accessioned2017-05-02T19:56:07Z
dc.date.available2017-05-02T19:56:07Z
dc.date.issued2016-10-01
dc.identifier.citationICON8 stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer. 2016, 27(suppl 6):861P Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw374.08
dc.identifier.urihttp://hdl.handle.net/10541/620312
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2799597/ICON8en
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleICON8 stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology-UCL, Londonen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record